Home/Filings/4/0001193125-25-308787
4//SEC Filing

Loew Caroline 4

Accession 0001193125-25-308787

CIK 0001971543other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 9:10 AM ET

Size

12.2 KB

Accession

0001193125-25-308787

Insider Transaction Report

Form 4
Period: 2025-12-05
Loew Caroline
DirectorChief Executive Officer
Transactions
  • Disposition to Issuer

    Ordinary Shares

    2025-12-05293,0590 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2025-12-05379,6900 total
    Exercise: $5.48Exp: 2033-07-02Ordinary Shares (379,690 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2025-12-0590,0250 total
    Exercise: $5.39Exp: 2034-02-28Ordinary Shares (90,025 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2025-12-05134,2250 total
    Exercise: $3.43Exp: 2035-03-02Ordinary Shares (134,225 underlying)
Footnotes (3)
  • [F1]Pursuant to the terms of the Transaction Agreement (the "Agreement"), dated August 20, 2025, by and among the Issuer, XRA 5 Corp. ("Sub"), a Delaware corporation and wholly-owned subsidiary of XOMA Royalty Corporation, a Nevada corporation, Sub acquired all the issued and to be issued share capital of the Issuer (the "Acquisition") for a cash purchase price of $2.035 per share (the "Scheme Consideration"), as of December 5, 2025 (the "Effective Time").
  • [F2]Includes the disposition of 220,148 unvested restricted stock units ("RSUs"). Pursuant to the Agreement, as of the Effective Time each RSU held by the Reporting Person that was outstanding as of immediately prior to the Effective Time (whether or not vested) was automatically cancelled and converted into the right to receive an amount equal to the Scheme Consideration.
  • [F3]Pursuant to the terms of the Agreement, at the Effective Time each option to purchase ordinary shares of Issuer that had an exercise price per share that was equal to or greater than the Scheme Consideration was cancelled and ceased to be outstanding, and no Scheme Consideration was delivered in exchange for such options.

Documents

1 file

Issuer

Mural Oncology plc

CIK 0001971543

Entity typeother

Related Parties

1
  • filerCIK 0001989488

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 9:10 AM ET
Size
12.2 KB